Cargando…
Phased implementation of pathogen‐reduced platelets in a health system facilitates increased manufacturing at the blood center
BACKGROUND: Pathogen reduction treatment (PRT) reduces the risk of transfusion‐transmitted infections from established and emerging organisms. Manufacturing, however, is complex. In our university health system, we phased in pathogen‐reduced platelets (PR PLTs) by patient population. We then assesse...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852374/ https://www.ncbi.nlm.nih.gov/pubmed/31408203 http://dx.doi.org/10.1111/trf.15480 |